FBR-NDs: a ferroptosis-inducing nanocomplex for targeted breast cancer therapy via immune modulation and redox-responsive drug delivery
FBR-NDs are a promising therapeutic strategy for breast cancer, combining ferroptosis induction with immune modulation. The ability to induce ferroptosis, enhance immune responses, and promote anti-tumor immunity makes FBR-NDs a potential candidate for cancer immunotherapy.
Authors
- Yunhao Sun (ORCID: https://orcid.org/0009-0008-9123-8124)
- jinjin chen (ORCID: https://orcid.org/0000-0002-3400-7986)
- L. L. Ma
- J Sun
- Ming Yin
Institutions
- Xuzhou Medical College (CN)
- Nantong University (CN)
- Yancheng First People's Hospital (CN)
- Binzhou People's Hospital (CN)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1186/s13058-026-02247-2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00